跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
recombinant PEDF therapy
首页
药物
recombinant PEDF therapy
recombinant PEDF therapy
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Raav vector compositions and methods for the treatment of choroidal neovascularization
US 2006193830 A1
申请人: HAUSWIRTH WILLIAM W
优先权: 2002
US
PEDF (Pigment Epithelial Derived Factor) gene PLGA nano compound as well as preparation method and use thereof
CN 101804209 B
申请人: UNIV SICHUAN
优先权: 2010
CN
Application of slow virus carrier mediated-PEDF (pigment epithelium derived factor) in inhibition of hematogenous metastasis of renal cell carcinoma
CN 104195175 A
申请人: FOURTH HOSPITAL OF HARBIN MEDICAL UNIVERSITY
优先权: 2014
CN
Adeno-associated virus-based age-related macular degeneration gene therapy product
CN 118360257 A
申请人: UNIV TIANJIN MEDICAL
优先权: 2023
CN
Adenovirus vector and application thereof in macular degeneration gene therapy
CN 118460615 A
申请人: UNIV TIANJIN MEDICAL
优先权: 2023
CN
PEDF mutant targeting VEGFR2 (vascular endothelial growth factor receptor 2) and application of PEDF mutant
CN 120518748 A
申请人: XIAMEN SHUOWANG PHARMACEUTICAL TECH CO LTD
优先权: 2025
CN
药物
反馈